A woman presented with metastatic breast cancer, having extensive lytic bony involvement of C2 vertebra and limited symptoms. We present the radiologic findings and case history.
CLiniCAL PreSentAtion
A 55 year old post-menopausal woman presented in September 2007 with 6 months of right-sided neck pain and 1 month of a pricking sensation in her right breast, which contained a lump. The neck pain was the dominant presenting complaint; she had tolerated the lump for several months.
On examination the upper cervical spine was swollen posteriorly with generalized spinal tenderness. The right breast contained a 7.5x6.5cm dominant nodule with a 2x2cm smaller nodule. Power in the upper limbs was 5/5, lower limbs 4+/5 bilaterally. No sensory defect was demonstrated. Neurologically she was otherwise unremarkable.
iMAGe FindinGS
Biopsy of the breast lump showed invasive ductal carcinoma. Immunohistochemistry was ER (2 to 3+) (80%), PR 2+ (80%), Cerb2 3+.
Plain film X-ray of the cervical spine showed expansion of the posterior elements of C2 vertebra with lytic infiltration. Computed tomography scan of the thorax showed a right breast mass, enlarged axillary lymph nodes and a small pulmonary nodule in the right lower lobe. Bone scan demonstrated metastatic disease.
Urgent magnetic resonance imaging of the spine showed a large soft tissue mass at C2 encircling the cord, with severe compression and distortion. The dens of C2 was also infiltrated by tumour. Multiple vertebral metastases were seen.
Neurosurgical opinion was sought. The family opted for conservative management in view of the multi-level disease and technically difficult surgical approach, which would have entailed transoral and posterior access, a tracheostomy, and likely intensive care requirements. A rigid cervical collar was placed. In the first instance, the patient received radiotherapy and hormone therapy with Letrozole and Herceptin, later changed to Exemestane and Herceptin. There was subsequent progression of disease in the breast, axillary lymph nodes and bone, following which she was offered Capecitabine and Herceptin. Due to financial concerns, the patient opted for Capecitabine single agent. When she progressed again, she was given Megestrol Acetate.
In April 2009 the patient expressed interest in resuming intravenous chemotherapy and was commenced on Adriamycin and Cyclophosphamide. This was discontinued after 1 cycle as she did not tolerate the regimen.
She remained ambulatory until further thoracic cord compression supervened in July 2009, resulting in paraplegia. She received further radiotherapy to the affected segments.
She was readmitted for urosepsis in August 2009 and April 2010. Following this last admission, she was admitted to a hospice. She passed away in June 2010, nearly 3 years from her initial diagnosis of metastatic breast cancer.
